Cancer Treatment Clinical Trials

1 recruiting

Cancer Treatment Trials at a Glance

7 actively recruiting trials for cancer treatment are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Amiens, Aurora, and Beijing. Lead sponsors running cancer treatment studies include Cristina García-Vivar, Dana-Farber Cancer Institute, and Centre Hospitalier Universitaire, Amiens.

Browse cancer treatment trials by phase

Treatments under study

About Cancer Treatment Clinical Trials

Looking for clinical trials for Cancer Treatment? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Treatment trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Treatment clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Ovarian CancerPrimary Peritoneal CancerFallopian Tube Carcinoma+4 more
Dana-Farber Cancer Institute240 enrolled6 locationsNCT06710548
Recruiting
Not Applicable

Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care

FatigueFatigue SymptomFatigue Related to Cancer Treatment+2 more
Karolinska Institutet190 enrolled1 locationNCT06786832
Recruiting
Phase 2

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

ThrombocytopeniaCancer Treatment-induced Thrombocytopenia
Zhejiang Cancer Hospital25 enrolled1 locationNCT07441720
Recruiting
Phase 1

VSV-02 Compassionate Use in Advanced Solid Tumors

Breast CancerLung CancerMelanoma+3 more
The First Affiliated Hospital of Xinxiang Medical College6 enrolled1 locationNCT07260591
Recruiting
Not Applicable

Web-based Intervention for Long-term Breast Cancer Survivors

Long-term Effects of Cancer TreatmentLong-term Effects Secondary to Cancer Therapy in Adults
Cristina García-Vivar182 enrolled1 locationNCT05322460
Recruiting

Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment

Multidisciplinary Consultation ProgramAdherence to Oral Anticancer TreatmentDrug Related Toxicity+1 more
Centre Hospitalier Universitaire, Amiens300 enrolled1 locationNCT04797143
Recruiting

Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

Personalized Cancer Treatment
Hua Li40 enrolled1 locationNCT06232213